chitosan has been researched along with dalteparin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Elson, C; Henderson, S; Kydonieus, A; Thanou, M | 1 |
| Kissel, T; Mao, S; Mei, D; Sun, W | 1 |
| Junyaprasert, VB; Mao, S; Na, L; Sun, W; Wang, J; Wang, Y; Zhang, T | 1 |
| Junyaprasert, VB; Li, C; Li, L; Li, Y; Mao, S; Sun, Y; Tian, Y; Wang, L | 1 |
| Abradelo, C; Aguilar, MR; García-Fernández, L; Peniche, C; Peniche, H; Reyes-Ortega, F; Rodríguez, G; San Román, J | 1 |
| Bagre, AP; Jain, K; Jain, NK | 1 |
| Duan, X; Guan, J; Li, L; Li, Y; Mao, S; Ni, R; Shi, C; Sun, Y; Wang, L; Zhang, X | 1 |
| Ding, J; Duan, X; Junyaprasert, VB; Li, J; Li, L; Li, Y; Mao, S; Sun, Y; Wang, L | 1 |
| Awad, GAS; Geneidi, AS; Ibrahim, SS; Mortada, ND; Osman, R | 1 |
| Chen, X; Dong, W; Kou, Y; Liu, C; Mao, S; Wang, X; Zhang, X | 1 |
| Álvarez-Mon, M; Asúnsolo, Á; Buján, J; Cifuentes, A; Coca, S; García-Honduvilla, N; Gómez-Gil, V; Ortega, MA; Román, JS | 1 |
| Arruda, IES; Chaves, LL; da Silva, DA; de Jesus Oliveira, AC; de La Roca Soares, MF; de Lemos Vasconcelos Silva, E; de Oliveira Silva Ribeiro, F; de Oliveira, TC; Patriota, YBG; Soares-Sobrinho, JL | 1 |
| Ataabadi, FV; Etebari, M; Oveissi, F; Taheri, A | 1 |
13 other study(ies) available for chitosan and dalteparin
| Article | Year |
|---|---|
N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules.
Topics: Adjuvants, Pharmaceutic; Administration, Oral; Animals; Anticoagulants; Area Under Curve; Biological Transport; Caco-2 Cells; Chitosan; Dextrans; Electric Impedance; Fluorescein-5-isothiocyanate; Heparin, Low-Molecular-Weight; Humans; Intestinal Mucosa; Macromolecular Substances; Male; Mannitol; Molecular Structure; Polymers; Rats; Rats, Wistar; Sulfonic Acids; Sulfur Oxides; Viscosity | 2007 |
Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and enoxaparin.
Topics: Anticoagulants; Chemistry, Pharmaceutical; Chitosan; Electrochemistry; Enoxaparin; Hydrogen-Ion Concentration; Light; Microscopy, Atomic Force; Molecular Weight; Nanoparticles; Particle Size; Polymers; Scattering, Radiation; Solubility | 2008 |
Bioadhesion and oral absorption of enoxaparin nanocomplexes.
Topics: Adhesiveness; Administration, Oral; Animals; Anticoagulants; Biological Availability; Blood Coagulation; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Stability; Enoxaparin; Hydrogen-Ion Concentration; Intestinal Absorption; Intestinal Mucosa; Male; Methylation; Microscopy, Atomic Force; Nanoparticles; Nanotechnology; Partial Thromboplastin Time; Particle Size; Polyethylene Glycols; Rats; Rats, Wistar; Solubility; Sulfhydryl Compounds; Surface Properties; Technology, Pharmaceutical; Temperature | 2010 |
Exploration of hydrophobic modification degree of chitosan-based nanocomplexes on the oral delivery of enoxaparin.
Topics: Adhesiveness; Administration, Oral; Animals; Anticoagulants; Biological Availability; Chitosan; Drug Carriers; Enoxaparin; Glycerides; Hydrophobic and Hydrophilic Interactions; Male; Mucins; Nanostructures; Partial Thromboplastin Time; Rats; Rats, Sprague-Dawley | 2013 |
Thermosensitive macroporous cryogels functionalized with bioactive chitosan/bemiparin nanoparticles.
Topics: Acrylic Resins; B-Lymphocytes; Biocompatible Materials; Cell Line; Cell Proliferation; Chitosan; Cryogels; Delayed-Action Preparations; Fibroblasts; Heparin, Low-Molecular-Weight; Humans; Kinetics; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Polymerization; Porosity; Temperature; Tissue Engineering; Tissue Scaffolds | 2013 |
Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Topics: Administration, Oral; Alginates; Animals; Anticoagulants; Biological Availability; Chitosan; Drug Carriers; Enoxaparin; Glucuronic Acid; Hexuronic Acids; Intestinal Mucosa; Nanoparticles; Rats; Rats, Sprague-Dawley; Venous Thrombosis | 2013 |
Uptake, transport and peroral absorption of fatty glyceride grafted chitosan copolymer-enoxaparin nanocomplexes: influence of glyceride chain length.
Topics: Animals; Anticoagulants; Caco-2 Cells; Chitosan; Diffusion; Enoxaparin; Glycerides; Humans; Male; Metabolic Clearance Rate; Nanocapsules; Nanocomposites; Oral Mucosal Absorption; Particle Size; Rats; Rats, Sprague-Dawley | 2014 |
In vitro and in vivo evaluation of chitosan graft glyceryl monooleate as peroral delivery carrier of enoxaparin.
Topics: Adhesiveness; Administration, Oral; Animals; Anticoagulants; Caco-2 Cells; Chitosan; Disease Models, Animal; Drug Carriers; Drug Compounding; Enoxaparin; Glycerides; Humans; Male; Mice, Inbred Strains; Molecular Structure; Particle Size; Pulmonary Embolism; Rats, Sprague-Dawley; Surface Properties | 2014 |
Polysaccharides-based nanocomplexes for the prolonged delivery of enoxaparin: In-vitro and in-vivo evaluation.
Topics: Animals; Anticoagulants; Chemistry, Pharmaceutical; Chitosan; Dextran Sulfate; Drug Carriers; Enoxaparin; Rats | 2017 |
Chitosan based polymer-lipid hybrid nanoparticles for oral delivery of enoxaparin.
Topics: Administration, Oral; Animals; Anticoagulants; Biological Availability; Chitosan; Drug Carriers; Drug Compounding; Drug Stability; Enoxaparin; Glycerides; Hydrophobic and Hydrophilic Interactions; Lipids; Male; Models, Animal; Nanoparticles; Oral Mucosal Absorption; Rats; Rats, Sprague-Dawley | 2018 |
Chitosan hydrogels functionalized with either unfractionated heparin or bemiparin improve diabetic wound healing.
Topics: Animals; Bandages, Hydrocolloid; Chitosan; Collagen Type I; Collagen Type III; Diabetes Mellitus, Experimental; Female; Heparin, Low-Molecular-Weight; Hydrogels; Macrophages; Myofibroblasts; Rats, Wistar; Skin; Surgical Wound; Time Factors; Transforming Growth Factor beta1; Wound Healing | 2020 |
Synthesis of Eudragit® L100-coated chitosan-based nanoparticles for oral enoxaparin delivery.
Topics: Chitosan; Drug Carriers; Drug Liberation; Enoxaparin; Nanoparticles; Particle Size | 2021 |
Preparation of chitosan nanoparticles for simultaneous drug delivery of dacarbazine and enoxaparin in melanoma.
Topics: Chitosan; Dacarbazine; Drug Delivery Systems; Enoxaparin; Humans; Melanoma; Nanoparticles | 2023 |